About this trial
An observational study of patients with hematologic, oncologic, and other relevant conditions undergoing bone marrow imaging, with longitudinal collection of imaging, treatment, and clinical outcome data to characterize bone marrow features and changes over time
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of a hematologic, oncologic, or other condition relevant to the study.
Availability of clinical, imaging, laboratory, treatment, and/or outcome data relevant to the study.
Ability to provide informed consent for prospective participation or, for pediatric participants, parent/legal guardian permission with assent when applicable.
Participants undergoing research MRI must be eligible for MRI according to institutional safety requirements.
Disqualifiers
Inability to provide required informed consent or parental/legal guardian permission for prospective participation.
Insufficient clinical information to support study participation
Pregnancy.
Contraindication to MRI will exclude participants from research-specific MRI but not necessarily from other study components.
Trial population
UT MD Anderson Cancer Center
Trial design
Cohort
Prospective
Treatments tested in this trial
Data Collection
Other interventionClinical, imaging, laboratory, treatment, and outcome data will be collected from institutional records and research assessments, as applicable.
Treatment groups
Trial outcomes
Primary outcomes
Bone marrow imaging characteristics.
Evaluation of bone marrow imaging findings and longitudinal changes in patients with hematologic, oncologic, and other relevant conditions.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.